As for cDC2s, the presentation of tumor antigens directly to CD4 T-cells—needed for CD8 T-cell activation—or indirectly by transferring tumor antigens to lymph node resident cDC2s represent the major roles of cDC2s in anti-tumor immunity [46]. This evidence concerns the gene CD8A and neoplasm.